Pot Gerda K, Battjes-Fries Marieke Ce, Patijn Olga N, Pijl Hanno, Witkamp Renger F, de Visser Marianne, van der Zijl Nynke, de Vries Maaike, Voshol Peter J
Department of Nutrition and Health, Louis Bolk Instituut, Bunnik, The Netherlands.
King's College London, Division of Diabetes and Nutritional Sciences, London, UK.
BMJ Nutr Prev Health. 2019 May 14;2(1):43-50. doi: 10.1136/bmjnph-2018-000012. eCollection 2019.
Prevalence of type 2 diabetes (T2D) is increasing rapidly and lifestyle interventions to reverse diabetes are seen as a possible solution to stop this trend. New practice-based evidence is needed to gain more insight in the actual, and above all scientific, basis for these claims.
This observational study with a pretest post-test design aimed to pilot a 6-month multicomponent outpatient group-based nutrition and lifestyle intervention programme on glycaemic control and use of glucose lowering medication in motivated T2D patients with a body mass index (BMI) >25 kg/m in the Netherlands (February 2015-March 2016).
74 T2D patients (56% female) aged 57.4±8.0 years with mean BMI 31.2±4.2 kg/m and mean waist circumference 105.4±10.2 cm were included in the study. Compared with baseline, mean HbA1c levels at 6 months were 5 mmol/mol lower (SD=10, p<0.001) and the number of participants with HbA1c levels ≤53 mmol/mol after intervention had increased (from 36% (n=26/72) to 60% (n=43/72)). At baseline, 90% of participants were taking at least one type of glucose lowering medication. At 6 months, 49% (n=35/72) of the participants had reduced their medication or eliminated it completely (13%). Secondary outcomes were significantly lower fasting glucose levels (- 1.2±2.6 mmol/L), body weight (-4.9±5.1 kg), BMI (-1.70±1.69 kg/m) and waist circumference (-9.4±5.0 cm). Plasma lipids remained unchanged except for a decrease in triglyceride levels. Furthermore, self-reported quality of life was significantly higher while experienced fatigue and sleep problems were significantly lower.
This pilot study showed that a 6-month multicomponent group-based program in a routine care setting could improve glycaemic control and reduce the use of glucose lowering medication in motivated T2D diabetics. A fully scaled study is needed to confirm these results.
2型糖尿病(T2D)的患病率正在迅速上升,通过生活方式干预来逆转糖尿病被视为阻止这一趋势的一种可能解决方案。需要新的基于实践的证据,以便更深入地了解这些说法的实际依据,尤其是科学依据。
这项采用前测后测设计的观察性研究旨在对荷兰一群有积极性的体重指数(BMI)>25kg/m²的T2D患者开展一项为期6个月的多组分门诊小组营养和生活方式干预计划,以观察其对血糖控制和降糖药物使用的影响(2015年2月至2016年3月)。
74例T2D患者(56%为女性)纳入研究,年龄57.4±8.0岁,平均BMI为31.2±4.2kg/m²,平均腰围105.4±10.2cm。与基线相比,6个月时平均糖化血红蛋白(HbA1c)水平降低了5mmol/mol(标准差=10,p<0.001),干预后HbA1c水平≤53mmol/mol的参与者人数增加(从36%(n=26/72)增至60%(n=43/72))。基线时,90%的参与者至少服用一种降糖药物。6个月时,49%(n=35/72)的参与者减少了用药或完全停用(13%)。次要结果显示空腹血糖水平显著降低(-1.2±2.6mmol/L)、体重(-4.9±5.1kg)、BMI(-1.70±1.69kg/m²)和腰围(-9.4±5.0cm)。除甘油三酯水平降低外,血脂保持不变。此外,自我报告的生活质量显著提高,而经历的疲劳和睡眠问题显著减少。
这项试点研究表明,在常规护理环境中开展的为期6个月的多组分小组计划可以改善有积极性的T2D糖尿病患者的血糖控制并减少降糖药物的使用。需要进行全面规模的研究来证实这些结果。